Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model. - Wikidata - wikimedia - TriplyDB

Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.

Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.

http://www.wikidata.org/entity/Q39879690

about

A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?Smooth Muscle-Targeted Overexpression of Peroxisome Proliferator Activated Receptor-γ Disrupts Vascular Wall Structure and Function Role of oxidized lipids in pulmonary arterial hypertension Metabolic Syndrome and the Lung Enhanced depolarization-induced pulmonary vasoconstriction following chronic hypoxia requires EGFR-dependent activation of NAD(P)H oxidase 2 Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.NADPH oxidases in vascular pathology.PPARγ attenuates hypoxia-induced hypertrophic transcriptional pathways in the heart.Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment.Puerarin Protects against Cardiac Fibrosis Associated with the Inhibition of TGF-β1/Smad2-Mediated Endothelial-to-Mesenchymal Transition.Time-dependent PPARγ Modulation of HIF-1α Signaling in Hypoxic Pulmonary Artery Smooth Muscle Cells.The Role of NOX4 and TRX2 in Angiogenesis and Their Potential Cross-Talk.Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension.Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1 PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B.Rosiglitazone inhibits angiotensin II-induced C-reactive protein production in human aortic endothelial cells through regulating AT(1)-ROS-MAPK signal pathway.The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation PPAR-γ regulates carnitine homeostasis and mitochondrial function in a lamb model of increased pulmonary blood flow Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?Circadian clock control of Nox4 and reactive oxygen species in the vasculature.Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone.Peroxisome proliferator-activated receptor γ inhibits pulmonary hypertension targeting store-operated calcium entry Effects of chrysin (5,7-dihydroxyflavone) on vascular remodeling in hypoxia-induced pulmonary hypertension in rats Chronic hypoxia promotes pulmonary artery endothelial cell proliferation through H2O2-induced 5-lipoxygenase.Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.PPARγ ligands regulate NADPH oxidase, eNOS, and barrier function in the lung following chronic alcohol ingestion Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling.Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension.PPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21.Update on pulmonary hypertension 2009.Activation of peroxisome proliferator-activated receptor γ ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis Serotonylated fibronectin is elevated in pulmonary hypertension Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases.Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis.Enhanced caveolin-1 expression in smooth muscle cells: Possible prelude to neointima formation.Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension.Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.Peroxisome Proliferator-Activated Receptor γ-Mediated Inhibition on Hypoxia-Triggered Store-Operated Calcium Entry. A Caveolin-1-Dependent Mechanism.

P2860

Q27026643-426EBFB8-36EA-417A-A30D-54BCBE21441D Q27315042-8A024F6A-22D4-4890-9268-8765E54758BA Q28078566-2D06A7E4-0971-4D82-A78A-9C6E237B6124 Q28384152-4E7D9301-2E39-4D52-9DF1-13FF9F74469D Q28582157-3B73BC8B-3C8E-45AD-BED3-6E85A3E6B753 Q30429980-33AD4818-F369-46A5-82CD-54F9C3D63EE0 Q33593476-D5C32D25-E22A-4427-A4BB-020A15FA4F6C Q33632089-37A589EE-DFAD-471F-802C-33DEBF3BF15F Q33738569-7F6103C9-2648-47DA-9608-6F080ED8EED8 Q33746493-393A40ED-E404-4AA8-850A-87DE9B01CD79 Q33790719-FFDA6DAE-F164-4FC6-986B-F0B4905CE11F Q33831356-56948145-9F31-400F-8016-468CBDBCED7D Q33845086-E7363FA1-E60E-461C-B2B7-0D7D523964F9 Q34046462-5C8B7FCA-AA56-479F-9C18-2AE0F246E06B Q34178976-1D232A93-0E17-4082-ADF2-7817AC088EA6 Q34212735-90072218-37C3-44A0-92AC-92F23ABB66F6 Q34290152-92F42B3C-5965-450F-AFA8-FF096A3AE9CB Q34294854-E5AAB15C-F786-4FD9-8235-D829A7191B61 Q34409704-4BD3C5C3-A2E8-4A65-A7CE-5630A769BC8C Q34897476-8A64820D-076A-40A6-AE72-088C1BE60870 Q35036598-F988D931-F675-470C-892B-BFCBF9707663 Q35087009-93808221-3C36-46B9-B07E-3185B8DFE95A Q35102314-01E0B5F3-D0C5-4A21-8C2B-B44AC9E68F4C Q35123675-5355D42A-002C-43AA-A88B-9DBCBB30C438 Q35183085-7782436B-7C5B-4AED-B07C-FB9D539B6A9F Q35219809-D149F613-F709-42CD-8AC3-9142F0F0CB39 Q35403487-F00F923D-4842-4823-8308-FBF023AD5964 Q35601455-7107DBB1-9114-4EF5-8D73-8A5DA82EC0BC Q35601475-74517345-A9A1-4A1B-AB49-2D5802D8988F Q35711530-00AC1884-9A0C-4EEF-A49D-3EEEFD05E056 Q35716098-E1925FBD-DC80-4CC1-9F9D-B79863BF4941 Q35803453-C65006DB-A407-4A3F-9448-DE950D0AA10C Q35954579-BEABCB10-6117-4C5E-A18E-237B32F80A94 Q36045577-363C7BE2-B6A8-4EA9-985A-6A10760DC312 Q36063833-8E1859D2-F4BE-474A-B584-6002333C6A5D Q36093802-A056261C-2FE8-4701-9CA5-9E3C0FEBA764 Q36204876-B7DA7310-BD68-400F-A185-2A379CCA304E Q36340848-B8F6A6CC-A266-4D7D-88D4-637DC1CE7AFC Q36549041-45188645-4926-4282-AFE6-AC674EEDAEEB Q36549129-5F48D42C-721D-4C47-8C9D-126AF894CDC3

P2860

Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.

http://www.wikidata.org/entity/Q39879690

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.

@en

Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.

@nl

type

label

Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.

@en

Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.

@nl

prefLabel

Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.

@en

Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.

@nl

P1433

Q39879690-FF791031-6024-43E9-97A0-1C584EC43B00

P1476

Q39879690-674A66D4-2F4F-49F9-B2D7-A41127E0FED9

P2093

Q39879690-1CA52C57-C6E3-4F92-B615-563A2AB25333

Q39879690-22EC31FD-4D5A-4E9B-967B-87CD98491D9A

Q39879690-60B27AAB-6DDE-47F9-A87E-9D2E00FC4FC7

Q39879690-88692AB8-7934-40CA-8C80-0E4DB3F49FCC

Q39879690-891CBFFF-7360-4302-913F-7C62E78638A9

Q39879690-952E6F08-F5ED-4FFE-9E8B-9796FD2B9CC4

Q39879690-9CF7F858-368D-46CB-B766-F47290CD7729

P2860

Q39879690-088FF0BD-52A7-4B51-A795-EC499A2E34DF

Q39879690-0CA37BBF-6B96-4E56-818F-330F5F54E93C

Q39879690-1BCD4C2C-9581-4245-8286-25ECAE64D284

Q39879690-1CC175DC-EEDC-473B-B75C-82EFF459DCD3

Q39879690-20365105-654B-40B7-BC59-9FA1BFCEB8BA

Q39879690-24E833C1-5021-4746-A191-DA9006113FF0

Q39879690-2D182D6D-9C97-44E3-B009-E6D1F301A146

Q39879690-2ED6415B-6599-4278-ACF7-673DE0A87CE3

Q39879690-33E8B24D-F382-4DE2-A4A9-9EE0ECC3544F

Q39879690-3D41FD25-C820-4D1E-AA35-9B0ACFE0624B

P304

Q39879690-5BBFBB6E-12BC-412C-BB87-8BF477523139

P31

Q39879690-F1D7FE71-25E1-4FAF-9910-327684CF93E8

P356

Q39879690-26D0E502-C227-47C8-969D-8170155961BF

P433

Q39879690-7A55FFCF-E6E3-4058-A097-74FB4D0F4BC3

P478

Q39879690-3609F425-6F6D-40CD-A6D0-3291DB8AF5B6

P577

Q39879690-BDBDD2D9-AA2D-45BE-9B46-41D305C8B2BB

P698

Q39879690-0FB3DD1F-D997-44F4-AD27-8B96672FFEAF

P921

Q39879690-60B5EB5D-A73F-44E8-BA14-3AACBD1295C6

Q39879690-66B5F430-FF26-41B6-B794-73197047B576

P932

Q39879690-1CC600A3-4C3A-4258-86CB-C27389AD0451

P356

RCMB.2008-0132OC

P1433

American Journal of Respiratory Cell and Molecular Biology

P1476

Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.

@en

P2093

C Michael Hart

http://www.w3.org/2001/XMLSchema#string

Dean J Kleinhenz

http://www.w3.org/2001/XMLSchema#string

Erik R Walp

http://www.w3.org/2001/XMLSchema#string

Jennifer M Bland

http://www.w3.org/2001/XMLSchema#string

Patrick O Mitchell

http://www.w3.org/2001/XMLSchema#string

Rachel E Nisbet

http://www.w3.org/2001/XMLSchema#string

Roy L Sutliff

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase

Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation

Reversible inactivation of the tumor suppressor PTEN by H2O2

Reversal of experimental pulmonary hypertension by PDGF inhibition.

PDGF signaling in pulmonary arterial hypertension.

An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension.

PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer

Emerging roles of PPARs in inflammation and immunity.

The PDGF family: four gene products form five dimeric isoforms.

P304

482-490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1165/RCMB.2008-0132OC

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19520921

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

2848739

http://www.w3.org/2001/XMLSchema#string